Hormonal and Body Composition Predictors of Soluble Leptin Receptor, Leptin, and Free Leptin Index in Adolescent Girls with Anorexia Nervosa and Controls and Relation to Insulin Sensitivity
Madhusmita Misra,
Karen K. Miller,
Cecilia Almazan,
Kavitha Ramaswamy,
Avichal Aggarwal,
David B. Herzog,
Gregory Neubauer,
Jeffrey Breu and
Anne Klibanski
Neuroendocrine Unit (M.M., K.K.M., C.A., K.R., A.A., A.K.), and Eating Disorders Unit (D.B.H.), Massachusetts General Hospital and Harvard Medical School; Pediatric Endocrine Unit (M.M.), Massachusetts General Hospital for Children and Harvard Medical School; Core Laboratory (G.N.), General Clinical Research Center, Massachusetts General Hospital, Boston, Massachusetts 02114; and Core Laboratory (J.B.), General Clinical Research Center, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139
Address all correspondence and requests for reprints to: Anne Klibanski, M.D., BUL 457B, Neuroendocrine Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114. E-mail: aklibanski{at}partners.org.
Anorexia nervosa (AN) is associated with very low levels ofleptin, a cytokine secreted by adipose tissue and known to suppressappetite. Leptin may play a permissive role in onset of pubertyand in resumption of gonadal function in conditions of undernutrition.The soluble leptin receptor (sOB-R) is the main leptin bindingprotein, and the ratio of serum leptin to sOB-R provides a measureof the free leptin index (FLI), which may be a more accuratedeterminant of leptin function. Determinants of sOB-R and FLIhave not been examined in an adolescent population. We examinedlevels of sOB-R, leptin, and FLI, and body composition and hormonaldeterminants of these variables in 23 adolescent girls withAN and 21 healthy adolescent girls of comparable maturity prospectivelyover 1 yr. Measures of insulin resistance and adiponectin werealso examined. We determined changes in levels of sOB-R, leptin,and FLI with weight recovery (defined as an increase in bodymass index of 10%, n = 11), and with resumption of menstrualcycles (n = 13).
Girls with AN had significantly higher levels of sOB-R (P =0.0008) and significantly lower levels of leptin and FLI (P< 0.0001 for both) than healthy controls, and levels of FLIwere reduced more than levels of leptin in girls with AN comparedwith controls. An inverse correlation was noted between levelsof leptin and sOB-R for the group as a whole (r = 0.64,P < 0.0001) but not in girls with AN considered alone. Themost important predictor of levels of sOB-R was cortisol inthe group as a whole (r = 0.61, P < 0.0001) and in girlswith AN considered alone (r = 0.66, P = 0.0008). Other independentpredictors of sOB-R levels for the entire group were percentbody fat (r = 0.44, P = 0.003) and levels of IGF-I (r= 0.37, P = 0.01). The most important predictors of leptinand FLI were body mass index and percent body fat. An inverserelationship was noted between measures of insulin resistanceand sOB-R levels, whereas a positive association was noted betweenthese measures and leptin and FLI. Adiponectin values did notdiffer in girls with AN compared with healthy controls and didnot correlate with sOB-R, leptin, or FLI. Weight recovery resultedin significant decreases in levels of the sOB-R (24.7 ±1.7 to 17.6 ± 1.2 U/ml, P = 0.004), and increases inlevels of leptin (4.4 ± 1.0 to 13.7 ± 2.9 µg/liter,P = 0.02). Resumption of menstrual function, but not weightrecovery alone, was associated with significant increases inFLI (0.19 ± 0.04 to 0.50 ± 0.09 µg/U x 103,P = 0.02).
We demonstrate an increase in levels of sOB-R and a decreasein the FLI in adolescent girls with AN, and also demonstratethat cortisol is the most important predictor of levels of sOB-Rin this condition. Levels of leptin and FLI, conversely, areprimarily predicted by body composition. Weight recovery isassociated with a decrease in sOB-R and an increase in leptin.Resumption of menses is associated with significant increasesin the FLI, suggesting that free leptin may be an importantdeterminant of menstrual recovery.
This work was supported, in part, by National Institutes ofHealth Grants M01-RR-01066, DK 5262505, and DK 062249.
Abbreviations: AN, Anorexia nervosa; BMI, body mass index; cr,creatinine; DXA, dual-energy x-ray absorptiometry; FLI, freeleptin index; HOMA-IR, homeostasis model of assessment insulinresistance; sOB-R, soluble leptin receptor; UFC, urinary freecortisol.
This article has been cited by other articles:
M. T. G. De Alvaro, M. T. Munoz-Calvo, V. Barrios, G. Martinez, G. A. Martos-Moreno, F. Hawkins, and J. Argente Regional fat distribution in adolescents with anorexia nervosa: effect of duration of malnutrition and weight recovery
Eur. J. Endocrinol.,
October 1, 2007;
157(4):
473 - 479.
[Abstract][Full Text][PDF]
M. Misra, K. K. Miller, J. Cord, R. Prabhakaran, D. B. Herzog, M. Goldstein, D. K. Katzman, and A. Klibanski Relationships between Serum Adipokines, Insulin Levels, and Bone Density in Girls with Anorexia Nervosa
J. Clin. Endocrinol. Metab.,
June 1, 2007;
92(6):
2046 - 2052.
[Abstract][Full Text][PDF]
R. K. Stoving, J.-W. Chen, D. Glintborg, K. Brixen, A. Flyvbjerg, K. Horder, and J. Frystyk Bioactive Insulin-Like Growth Factor (IGF) I and IGF-Binding Protein-1 in Anorexia Nervosa
J. Clin. Endocrinol. Metab.,
June 1, 2007;
92(6):
2323 - 2329.
[Abstract][Full Text][PDF]
D. Modan-Moses, D. Stein, C. Pariente, A. Yaroslavsky, A. Ram, M. Faigin, R. Loewenthal, E. Yissachar, R. Hemi, and H. Kanety Modulation of Adiponectin and Leptin during Refeeding of Female Anorexia Nervosa Patients
J. Clin. Endocrinol. Metab.,
May 1, 2007;
92(5):
1843 - 1847.
[Abstract][Full Text][PDF]
M. Misra, P. Tsai, E. J Anderson, J. L Hubbard, K. Gallagher, L. A Soyka, K. K Miller, D. B Herzog, and A. Klibanski Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents.
Am. J. Clinical Nutrition,
October 1, 2006;
84(4):
698 - 706.
[Abstract][Full Text][PDF]
G. A Martos-Moreno, V. Barrios, and J. Argente Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: relationship with sex steroids
Eur. J. Endocrinol.,
September 1, 2006;
155(3):
429 - 434.
[Abstract][Full Text][PDF]
R. Brauner, C. Trivin, M. Zerah, J.-C. Souberbielle, F. Doz, C. Kalifa, and C. Sainte-Rose Diencephalic Syndrome due to Hypothalamic Tumor: A Model of the Relationship between Weight and Puberty Onset
J. Clin. Endocrinol. Metab.,
July 1, 2006;
91(7):
2467 - 2473.
[Abstract][Full Text][PDF]
M. Misra, K. K. Miller, P. Tsai, K. Gallagher, A. Lin, N. Lee, D. B. Herzog, and A. Klibanski Elevated Peptide YY Levels in Adolescent Girls with Anorexia Nervosa
J. Clin. Endocrinol. Metab.,
March 1, 2006;
91(3):
1027 - 1033.
[Abstract][Full Text][PDF]
S. Hahn, U. Haselhorst, B. Quadbeck, S. Tan, R. Kimmig, K. Mann, and O. E Janssen Decreased soluble leptin receptor levels in women with polycystic ovary syndrome
Eur. J. Endocrinol.,
February 1, 2006;
154(2):
287 - 294.
[Abstract][Full Text][PDF]
M. C. Henson and V. D. Castracane Leptin in Pregnancy: An Update
Biol Reprod,
February 1, 2006;
74(2):
218 - 229.
[Abstract][Full Text][PDF]
M. Misra, K. K. Miller, V. Stewart, E. Hunter, K. Kuo, D. B. Herzog, and A. Klibanski Ghrelin and Bone Metabolism in Adolescent Girls with Anorexia Nervosa and Healthy Adolescents
J. Clin. Endocrinol. Metab.,
September 1, 2005;
90(9):
5082 - 5087.
[Abstract][Full Text][PDF]
M. Misra, K. K. Miller, K. Kuo, K. Griffin, V. Stewart, E. Hunter, D. B. Herzog, and A. Klibanski Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents
Am J Physiol Endocrinol Metab,
September 1, 2005;
289(3):
E373 - E381.
[Abstract][Full Text][PDF]
M. Misra, K. K. Miller, K. Kuo, K. Griffin, V. Stewart, E. Hunter, D. B. Herzog, and A. Klibanski Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents
Am J Physiol Endocrinol Metab,
August 1, 2005;
289(2):
E347 - E356.
[Abstract][Full Text][PDF]